Mucosal permeability and mast cells as targets for functional gastrointestinal disorders

被引:31
|
作者
Keita, Asa V. [1 ]
Soderholm, Johan D. [1 ,2 ]
机构
[1] Linkoping Univ, Div Surg Orthoped & Oncol, Dept Clin & Expt Med, Linkoping, Sweden
[2] Cty Council Ostergotland, Dept Surg, Linkoping, Sweden
基金
瑞典研究理事会;
关键词
IRRITABLE-BOWEL-SYNDROME; VASOACTIVE INTESTINAL POLYPEPTIDE; DILATED INTERCELLULAR SPACES; EPITHELIAL BARRIER; ABDOMINAL-PAIN; IMMUNE ACTIVATION; REFLUX DISEASE; COLONIC-MUCOSA; STRESS; MICROBIOTA;
D O I
10.1016/j.coph.2018.08.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The intestinal mucosa is constantly exposed to harmful lumina! content, and uptake is closely controlled and regulated by neuro-immune factors. If control is broken, it might lead to ongoing enhanced mucosal permeability, potentially resulting in functional gastrointestinal disorders. The importance of mast cells in the regulation of the mucosal barrier has become obvious, and increased numbers and more activated mast cells have been observed in irritable bowel syndrome, functional dyspepsia and gastroesophageal reflux disease. To target the disturbed mucosal permeability, directly or via mast cells, is therefore currently of major interest. For example, administration of mast cell stabilizers and probiotics have shown promising effects in patients with functional gastrointestinal disorders.
引用
收藏
页码:66 / 71
页数:6
相关论文
共 50 条
  • [1] Functional gastrointestinal disorders and mast cells: implications for therapy
    Barbara, G
    Stanghellini, V
    De Giorgio, R
    Corinaldesi, R
    NEUROGASTROENTEROLOGY AND MOTILITY, 2006, 18 (01) : 6 - 17
  • [2] Mast cells in gastrointestinal disorders
    Bischoff, Stephan C.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 778 : 139 - 145
  • [3] The Intestinal Microenvironment and Functional Gastrointestinal Disorders
    Barbara, Giovanni
    Feinle-Bisset, Christine
    Ghoshal, Uday C.
    Santos, Javier
    Vanner, Stepen J.
    Vergnolle, Nathalie
    Zoetendal, Erwin G.
    Quigley, Eamonn M.
    GASTROENTEROLOGY, 2016, 150 (06) : 1305 - +
  • [4] The role of mast cells in functional GI disorders
    Wouters, Mira M.
    Vicario, Maria
    Santos, Javier
    GUT, 2016, 65 (01) : 155 - 168
  • [5] Quantification of Mucosal Mast Cells in the Gastrointestinal Tract A Primer for Practicing Pathologists
    Genta, Robert M.
    Turner, Kevin O.
    Collins, Margaret H.
    Wechsler, Joshua B.
    Arva, Nicoleta C.
    Pletneva, Maria A.
    Dellon, Evan S.
    Walker, Marjorie M.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2024, 148 (02) : e25 - e35
  • [6] Intestinal Permeability in Children with Functional Gastrointestinal Disorders: The Effects of Diet
    Giorgio, Valentina
    Margiotta, Gaia
    Stella, Giuseppe
    Di Cicco, Federica
    Leoni, Chiara
    Proli, Francesco
    Zampino, Giuseppe
    Gasbarrini, Antonio
    Onesimo, Roberta
    NUTRIENTS, 2022, 14 (08)
  • [7] Functional Gastrointestinal Disorders
    Duffy, Molly
    Boggiano, Victoria L.
    Ganesh, Ravindra
    Mueller, Michael
    PRIMARY CARE, 2023, 50 (03): : 429 - 446
  • [8] Eosinophils and mast cells as therapeutic targets in pediatric functional dyspepsia
    Craig A Friesen
    Jennifer V Schurman
    Jennifer M Colombo
    Susan M Abdel-Rahman
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2013, (04) : 86 - 96
  • [9] What Is the Value of Counting Mast Cells in Gastrointestinal Mucosal Biopsies?
    Panarelli, Nicole C.
    Hornick, Jason L.
    Yantiss, Rhonda K.
    MODERN PATHOLOGY, 2023, 36 (02)
  • [10] Symptoms of mast cell activation syndrome in functional gastrointestinal disorders
    Wilder-Smith, Clive H.
    Drewes, Asbjorn M.
    Materna, Andrea
    Olesen, Soren S.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (11) : 1322 - 1325